Latest Us Growth News

Page 6 of 14
Beforepay Group Limited reported a robust half-year performance with revenues climbing 18.7% and profit after tax nearly doubling, driven by growth in lending volumes and strategic expansion of its Carrington Labs credit analytics business.
Claire Turing
Claire Turing
26 Feb 2026
Cobram Estate Olives reported a widened half-year loss driven by higher oil costs and operating expenses, while progressing its US growth strategy with a major California acquisition.
Victor Sage
Victor Sage
20 Feb 2026
Zip Co has delivered a standout half-year performance with record cash earnings and upgraded FY26 guidance, driven by strong US market momentum and innovative product launches.
Claire Turing
Claire Turing
19 Feb 2026
Cyclopharm has achieved a key milestone with Technegas approved for clinical use at the US National Institutes of Health, marking a strategic advance in its American expansion. Installation is imminent, leveraging a federal procurement framework that could broaden Technegas applications beyond pulmonary embolism.
Ada Torres
Ada Torres
18 Feb 2026
American Tungsten & Antimony Ltd (ASX, AT4) has produced its first antimony ingots from its Utah project, validating its processing approach and advancing its US growth ambitions including a planned Nasdaq listing.
Maxwell Dee
Maxwell Dee
5 Feb 2026
Resolution Minerals has taken a significant step towards expanding its footprint in the US capital markets by lodging a registration statement with the SEC and launching an ADR facility, while divesting a non-core Alaskan asset to focus on key US projects.
Maxwell Dee
Maxwell Dee
3 Feb 2026
Xero Limited has outlined a bold AI strategy and detailed the integration of Melio to accelerate its US market growth, supported by new financial disclosures and a clear path to profitability.
Sophie Babbage
Sophie Babbage
3 Feb 2026
Xero Limited reveals new AI product demonstrations and updates on Melio’s integration, reaffirming ambitious US growth and FY28 revenue targets.
Sophie Babbage
Sophie Babbage
3 Feb 2026
Bubs Australia reports a 14% increase in half-year revenue, powered by a 47% jump in US sales, while other regions face challenges. The company remains optimistic about FDA approval and market recovery in H2 FY26.
Victor Sage
Victor Sage
30 Jan 2026
Artrya Limited has converted three US foundation partners into commercial customers, generating its first fee-per-scan revenues, while progressing FDA clearance for its Salix Coronary Flow module and expanding its clinical study network.
Ada Torres
Ada Torres
30 Jan 2026
Galilee Energy has secured the Zydeco Gas Project in Louisiana and raised $6.5 million to fast-track development, marking a pivotal shift towards becoming a mid-tier US gas producer.
Maxwell Dee
Maxwell Dee
30 Jan 2026
BetMakers Technology Group reported a robust Q2 FY26 with positive adjusted EBITDA and significant contract wins poised to fuel growth in the second half of the year.
Sophie Babbage
Sophie Babbage
29 Jan 2026

Browse the archive

Full archive